ArticleCancers2019

Dose-Dependent Sorafenib-Induced Immunosuppression Is Associated with Aberrant NFAT Activation and Expression of PD-1 in T Cells.

Renuka V Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.